Verana Health launches its Qdata Thyroid Eye Disease module

(Image Credit: AdobeStock/Iryna)

Verana Health announced the launch of its Qdata Thyroid Eye Disease (TED) module, a curated dataset that encompasses real-world data on more than 250,000 de-identified patients and provides information on extracting diagnoses from clinical notes in electronic health records.¹

Verana Health itself has an exclusive real-world data network of 90 million de-identified patients from more than 20,000 clinicians, stemming from its 3 exclusive data partnerships.

The Qdata TED module features exclusive data from the American Academy of Ophthalmology IRIS Registry (Intelligent Research in Sight). According to Verena Health, “Qdata TED provides clinical development, health economics and outcomes research (HEOR), and medical affairs teams unparalleled insights for this clinically-validated population, marking a critical step forward in the study and treatment of this challenging condition.”¹

The company stated that additional key variables will soon be added to the module, including the designation of TED severity (mild, moderate-to-severe, and sight-threatening) and Clinical Activity Score (CAS).

Sujay Jadhav, CEO of Verana Health, talked about the significance of the launch in a press release.

“Thyroid Eye Disease is diagnosed in roughly 1 million Americans each year, and severely diminishes quality of life,” said Jadhav. “There’s a critical unmet need for focused research and innovative treatment approaches for this condition, and real-world evidence can provide a catalyst for breakthroughs in disease management and therapeutic efficacy for this population, which can be challenging to identify.”

Recently, Verana Health announced of the development of Qdata Dry Eye Disease, which is also derived from the American Academy of Ophthalmology IRIS Registry.² Verana Health’s Qdata DED module includes extensive data on tests beyond what can be gleaned from codes alone such as tear break-up time and Schirmer’s test results, according to the company.

References:

1. Verana Health Announces Launch of Qdata® Thyroid Eye Disease. Press release; April24, 2024. Accessed April 23, 2024.

2. Verana Health Developing Qdata® Dry Eye Disease, the Largest Real-World Dataset of its Kind. Press release; April 4, 2024. Accessed April 23, 2024. https://www.globenewswire.com/news-release/2024/04/04/2857841/0/en/Verana-Health-Developing-Qdata-Dry-Eye-Disease-the-Largest-Real-World-Dataset-of-its-Kind.html